Nov 25 (Reuters) - Cephalon Inc:
* Immupharma ink $15 million option agreement for late- stage
experimental lupus medication
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223
8780))
(For more news, please click here)
COPYRIGHT
Copyright Thomson Reuters 2008. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including
by framing or similar means, is expressly prohibited without the prior written
consent of Thomson Reuters.